Marc Lippman
Founder at Aurora Biopharma, Inc.
Profile
Marc E.
Lippman was the founder of Ascenta Therapeutics, Inc. (founded in 2003) where he held the title of Director from 2010 to 2011.
Dr. Lippman is also the founder of Aurora Biopharma, Inc. Dr. Lippman's current jobs include Director at Alphageneron Pharmaceuticals, Inc. and Professor-Oncology at Georgetown Lombardi Comprehensive Cancer Center.
Dr. Lippman's former jobs include Chairman-Department of Medicine at The University of Miami Leonard M.
Miller School of Medicine (2017-2018), Independent Director at Seagen Inc. (2000-2022), Deputy Director at Sylvester Comprehensive Cancer Center (2008-2017), Director at Lombardi Cancer Research Center (1988-2001), and Professor at the University of Michigan (2001-2007).
Dr. Lippman's education includes a doctorate from Yale University (1968) and an undergraduate degree from Cornell University (1964).
Marc Lippman active positions
Companies | Position | Start |
---|---|---|
Aurora Biopharma, Inc.
Aurora Biopharma, Inc. BiotechnologyHealth Technology Aurora Biopharma, Inc. develops Chimeric Antigen Receptor (CAR) T therapy, cancer vaccines, and combinations with checkpoint Inhibitors services. It develops Aurora’s “Bionic” T Cells : CAR T-Cells engineered to kill cancer and Aurora’s Revolutionary CAR T cell Clinical Cancer Trials. The company was founded by Robert Brooks and Marc Lippman and is headquartered in Cambridge, MA. | Founder | - |
Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Georgetown Lombardi Comprehensive Cancer Center is a comprehensive cancer center designated by the National Cancer Institute (NCI) and is a part of Georgetown University Medical Center. It is located in Washington, D.C. and is supported in part by a National Cancer Institute Cancer Center Support Grant. It is the only comprehensive cancer center in the area and serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational, and clinical research, patient care, and community education and outreach. Georgetown Lombardi also offers a master’s degree program in cancer biology, prevention, and control in partnership with the University of the District of Columbia (UDC). | Corporate Officer/Principal | 2017-12-31 |
Alphageneron Pharmaceuticals, Inc.
Alphageneron Pharmaceuticals, Inc. BiotechnologyHealth Technology Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation. | Director/Board Member | - |
Former positions of Marc Lippman
Companies | Position | End |
---|---|---|
SEAGEN INC. | Director/Board Member | 2022-05-12 |
The University of Miami Leonard M. Miller School of Medicine | Corporate Officer/Principal | 2017-12-31 |
Sylvester Comprehensive Cancer Center | Corporate Officer/Principal | 2016-12-31 |
University of Michigan | Corporate Officer/Principal | - |
Lombardi Cancer Research Center | Director/Board Member | 2001-01-31 |
Training of Marc Lippman
Yale University | Doctorate Degree |
Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 10 |
---|---|
Perseus LLC
Perseus LLC Investment ManagersFinance Founded in 1995, Perseus LLC(Perseus) is a merchant banking and private equity fund management firm located in Bethesda, Maryland. | Finance |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Alpha Omega Alpha Honor Medical Society
Alpha Omega Alpha Honor Medical Society Miscellaneous Commercial ServicesCommercial Services Alpha Omega Alpha Honor Medical Society is a national medical honor society founded in 1902. The non-profit company is based in Menlo Park, CA. The society's mission is to foster the development of the next generation of medical researchers by recognizing high educational achievement, honoring gifted teaching, encouraging the development of leaders in academia and the community, and supporting the improvement of care for all. | Commercial Services |
Sylvester Comprehensive Cancer Center | |
Aurora Biopharma, Inc.
Aurora Biopharma, Inc. BiotechnologyHealth Technology Aurora Biopharma, Inc. develops Chimeric Antigen Receptor (CAR) T therapy, cancer vaccines, and combinations with checkpoint Inhibitors services. It develops Aurora’s “Bionic” T Cells : CAR T-Cells engineered to kill cancer and Aurora’s Revolutionary CAR T cell Clinical Cancer Trials. The company was founded by Robert Brooks and Marc Lippman and is headquartered in Cambridge, MA. | Health Technology |
Lombardi Cancer Research Center | |
Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Georgetown Lombardi Comprehensive Cancer Center is a comprehensive cancer center designated by the National Cancer Institute (NCI) and is a part of Georgetown University Medical Center. It is located in Washington, D.C. and is supported in part by a National Cancer Institute Cancer Center Support Grant. It is the only comprehensive cancer center in the area and serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational, and clinical research, patient care, and community education and outreach. Georgetown Lombardi also offers a master’s degree program in cancer biology, prevention, and control in partnership with the University of the District of Columbia (UDC). | Health Services |
Alphageneron Pharmaceuticals, Inc.
Alphageneron Pharmaceuticals, Inc. BiotechnologyHealth Technology Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Marc Lippman